J. Taubert

EVP, Worldwide Chair PharmaceuticalsatJohnson & Johnson· In proxies 2020–2025

Pay in FY2025+25% from the year before

J. Taubert was paid $14.0M in FY2025 (Dec), up 25%.

PayNo stock prices for these years

Pay is from the Summary Compensation Table of each Johnson & Johnson proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Johnson & JohnsonPublic company · 6 yr
- EVP, Worldwide Chair Pharmaceuticals2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?